Caas Capital Management LP Boston Scientific Corp Call Options Transaction History

Caas Capital Management LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 28, 2024	SELL	$72.96 - $84.0 $299,136 - $344,400	-4,100 Reduced 97.62%	100 $8,000
Q2 2024 Jul 15, 2024	BUY	$67.33 - $77.71 $282,786 - $326,382	4,200 New	4,200 $323,000
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $48,640 - $57,810	1,000 New	1,000 $57,000
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $572,643 - $635,381	12,700 New	12,700 $635,000
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $7.22 Million - $9.66 Million	-205,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $8.38 Million - $9.25 Million	205,000 New	205,000 $9.08 Million
Q3 2020 Nov 09, 2020	SELL	$34.44 - $42.23 $23.1 Million - $28.3 Million	-670,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $20.2 Million - $26.2 Million	670,000 New	670,000 $23.5 Million

1,542

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.